Drug Delivery Research Group News

Kumar-lab receives NIH funding (R01, NIDDK) May 2021 (PI: Kumar; MPI: Arora).
Dr. Kumar featured on The Medicine Maker ‘Power List 20 for 2021’.
Our work on “Nanoparticles that do not compete with endogenous ligands–molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans” just accepted for publication in Journal of Controlled Release, congratulations D. Zou/M. Kumar et al., Also this is the first paper with Dr. Shah,The State University of New York at Buffalo, longtime collaborator on PK/PBPK modeling.
The group moved to the University of Alabama in Tuscaloosa, effective Jan 14, 2021.